Nutrition therapy for patients with myeloid and lymphoid malignancies
Abstract
Patients being treated for myeloid and lymphoid malignancies, particularly those by high dose chemotherapy and/or radiotherapy, are vulnerable to malnutrition and any complications so arising. All efforts for ensuring normal nutrition in such patients can benefit their clinical status/outcomes, quality of life and life expectancy. Besides identifying any malnutrition, attention should also be focused on how the body’s mechanisms compensate and prevent adverse events from developing as a result of this condition. The most important of these aspects are the extent of patient nutrition before, during and after treatment, (and in defining malnutrition whenever it occurs), together with how nutrients are consumed, digested and absorbed. Determining such factors make it thereby possible to formulate a detailed nutritional plan tailored to the patient needs and thus support their basic cancer treatment.
Keywords: nutritiondietoral nutritional supportchemotherapyleukemialymphoma
References
- Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004; 4(4): 277–284.
- Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006; 14(9): 890–900.
- Beutheu Youmba S, Belmonte L, Galas L, et al. Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways. J Pediatr Gastroenterol Nutr. 2012; 54(4): 463–470.
- Niscola P, Romani C, Cupelli L, et al. Mucositis in patients with hematologic malignancies: an overview. Haematologica. 2007; 92(2): 222–231.
- Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res. 2009; 16(1): 1–12.
- Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008; 52(1): 61–77.
- Skipworth RJE, Stewart GD, Dejong CHC, et al. Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr. 2007; 26(6): 667–676.
- Esfahani A, Ghoreishi Z, Nikanfar A, et al. Influence of chemotherapy on the lipid peroxidation and antioxidant status in patients with acute myeloid leukemia. Acta Med Iran. 2012; 50(7): 454–458.
- Banks WA. Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier. Nutrition. 2001; 17(5): 434–437.
- Bing C, Russell ST, Beckett EE, et al. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer. 2002; 86(4): 612–618.
- Russell ST, Hirai K, Tisdale MJ. Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer. 2002; 86(3): 424–428.
- Kim H, Kataru RP, Koh GY. Inflammation-associated lymphangiogenesis: a double-edged sword? J Clin Invest. 2014; 124(3): 936–942.
- Whitehouse AS, Tisdale MJ. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB. Br J Cancer. 2003; 89(6): 1116–1122.
- Busquets S, Sanchís D, Alvarez B, et al. In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Lett. 1998; 440(3): 348–350.
- Gröber U. Antioxidants and Other Micronutrients in Complementary Oncology. Breast Care. 2009; 4(1): 13–20.
- Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007; 2(2): 219–236.
- Oray M, Abu Samra K, Ebrahimiadib N, et al. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016; 15(4): 457–465.
- Szuławska A, Czyż M. Molekularne mechanizmy działania antracyklin. Post Hig Med Dośw. 2006; 60: 78–100.
- Fijlstra M. Nutrient digestion and absorption during chemotherapy-induced intestinal mucositis in the rat. Doctoral thesis. University of Groningen, Groningen 2012.
- Melnyk M, Casey RG, Black P, et al. Enhanced recovery after surgery (ERAS) protocols: Time to change practice? Can Urol Assoc J. 2011; 5(5): 342–348.
- Kalinka-Warzocha E, Warzocha K. Zasady profilaktyki nudności i wymiotów indukowanych chemioterapią i radioterapią u chorych leczonych z powodu nowotworów układów krwiotwórczego i chłonnego. Hematologia. 2014; 5: 332–339.
- Łyszkowska M. Wpływ emulsji tłuszczowych na układ immunologiczny. Post Żyw Klin. 2015; 35: 33–38.
- Bükki J, Stanga Z, Tellez FB, et al. Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia. Nutr Cancer. 2013; 65(6): 834–842.
- Kłęk S, Jarosz J, Jassem J. Polskie Rekomendacje Żywienia Dojelitowego i Pozajelitowego w ogii — część II: żywienie drogą przewodu pokarmowego (żywienie dojelitowe). Onkol Prakt Klin. 2013; 6: 209–215.
- Gröber U, Holzhauer P, Kisters K, et al. Micronutrients in Oncological Intervention. Nutrients. 2016; 8(3): 163.
